BioSpace News Archive

Mr. Costa joined Aquestive’s Board in 2015 bringing over 40 years of experience in the pharmaceutical, healthcare and life sciences industries, as well as leadership in the legal sector.

All of these contracts represent orders for custom designed, advanced biological air and gas emissions abatement equipment for delivery within 2018 and early 2019.

Bright Health brings its unique “Care Partner Health Plan” model to New York City’s seniors

Nature-based regimen delivers improved skin health vs. dermatologist-recommended synthetic regimen

OrthoTrophix presented primary results of A Randomized, Double-blind, Placebo-controlled, Multi-dose Phase 2 Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects with Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees at the most recent American College of Rheumatology meeting

ONPATTRO Approval Triggers Royalty to Arbutus

The top-performing advertising and marketing agencies that specialize in specific industry segments, such as automotive, finance, healthcare, and legal, were announced by Clutch, a leading B2B research, ratings, and reviews company.

Specialty pharmacy to support bringing new FDA-approved medicine to patients

This represents 36 consecutive months of dividends declared since the Series A Preferred Stock was initially sold in November 2015.

iCAN:Israel-Cannabis is pleased to announce that it has entered into a Memorandum of Understanding (“MoU”) with Yom Chai, Ltd to co-found the development and clinical validation of a range of cannabis based products.